Background
==========

Oral cavity cancers form a significant percentage of cancers in India. Tobacco chewing and alcohol are dominant causes \[[@b1-poljradiol-82-92]\]. They are classified into following subsites \[[@b2-poljradiol-82-92]\]:

1.  Buccal mucosa;

2.  Alveolus and gingival;

3.  Hard palate;

4.  Tongue and floor of the mouth.

MRI is used to assess the extent of loco-regional tumor spread, depth of invasion and extent of lymphadenopathy. The invasion of the floor of the mouth by the tumor is depicted well in the coronal plane \[[@b3-poljradiol-82-92]--[@b5-poljradiol-82-92]\]. Non-contrast T1W sequences demonstrate cortical erosion and marrow invasion. Contrast-enhanced T1W images help assess marrow invasion \[[@b6-poljradiol-82-92]\], perineural spread, soft tissue extent, tumor thickness and best demonstrate necrosis in nodes \[[@b7-poljradiol-82-92]\]. The T2W images are sensitive to the presence of tumor tissue, which is usually hyperintense compared with the surrounding muscles \[[@b3-poljradiol-82-92]--[@b5-poljradiol-82-92]\].

The staging of oral cavity squamous cell carcinoma (SCC) is currently based on American Joint Committee on Cancer (AJCC) criteria \[[@b3-poljradiol-82-92],[@b8-poljradiol-82-92]\] ([Table 1](#t1-poljradiol-82-92){ref-type="table"}).

Aims and objectives
-------------------

Evaluation of the role of MRI in loco-regional staging of malignant lesions of the oral cavity and to correlate the MRI findings with clinical/surgical findings and anatomical-pathological findings, wherever possible.

Material and Methods
====================

This was a prospective study comprising fifty patients of all age groups with malignant lesions involving the oral cavity. An initial Informed consent was taken. The following patients were excluded from the study:

1.  Those with any contraindication to undergo MRI;

2.  Those having any previous history of surgical treatment of the oral cavity.

The clinical history and detailed local examination of all the patients was recorded. Examination of the mucosa of the cheek, vestibule of the mouth, gums in both upper and lower jaws, hard and soft palate, floor of the mouth, retromolar trigone, tonsils and pillars was done to look for any ulcer, mass and bulge. Examination of the tip, dorsum, lateral borders and undersurface of the tongue was done to look for any ulcers, white patch and proliferative growth. Movements of the tongue were looked for, with the base of the tongue and vallecula being examined by indirect laryngoscopy and finger palpation. Tumor data, including site, subsite and extent (infiltration of the surrounding structures) were collected to carry out clinical TNM staging. (AJCC Staging system -- [Table 1](#t1-poljradiol-82-92){ref-type="table"}).

After clinical staging was made, MRI was conducted in each patient included in the study. Afterwards surgery and histopathological staging were performed, wherever possible.

MR technique
------------

MR scan was carried out on Philips Gyroscan Achieva 1.5 Tesla unit.

MR imaging protocol
-------------------

T1W images were acquired in all planes (axial, sagittal and coronal). The T2W images and diffusion weighted images were acquired in the axial plane. STIR images were acquired in the coronal and sagittal planes. The intravenous contrast used was Gadopentate dimeglumine (0.1 mmol/kg) ([Table 2](#t2-poljradiol-82-92){ref-type="table"}).

Results
=======

A total of fifty patients were included in the study. After an initial thorough clinical examination, Magnetic Resonance Imaging was done. Data were analyzed using the Statistical Package for the Social Sciences -- version 18. The observations found clinically, on histopathology examination and on MR imaging were correlated using Pearson's chi-squared test and kappa index. The observations are as follows:

The present study comprised of all oral cavity cancers of squamous cell type. The highest number of patients were found to have tongue malignancy constituting about 82% of the patients followed by gingival and buccal mucosa malignancy which constitutes about 18% of the total number of patients ([Table 3](#t3-poljradiol-82-92){ref-type="table"}). 32% of the patients belonged to age group of 51--60 years, which was the maximum followed by the age group of 41--50 years comprising of 26% of the patients ([Table 4](#t4-poljradiol-82-92){ref-type="table"}). The incidence of the oral cancers is higher in males constituting 96% of total patients ([Table 5](#t5-poljradiol-82-92){ref-type="table"}). There was moderate agreement (k=0.537) for the T stage between the clinical and MRI staging assessments as shown in [Table 6](#t6-poljradiol-82-92){ref-type="table"}. N stage agreement between MRI and clinical staging assessments was fair (k=0.328) as shown in [Table 7](#t7-poljradiol-82-92){ref-type="table"}. In 22 patients, the confirmatory diagnosis was made by surgery/histopathology. Good/substantial (k=0.790) agreement for the T stage was seen between MRI and histopathology staging assessments as depicted in [Table 8](#t8-poljradiol-82-92){ref-type="table"}. The agreement for the N stage was moderate (k=0.458) between MRI and histopathology staging assessments ([Table 9](#t9-poljradiol-82-92){ref-type="table"}). The agreement for the T stage was poor (k=0.085) between the clinical and histopathology staging assessments ([Table 10](#t10-poljradiol-82-92){ref-type="table"}). [Table 11](#t11-poljradiol-82-92){ref-type="table"} shows that the agreement for the N stage was poor (k=0.185) between the clinical and histopathology staging assessments.

Discussion
==========

Oral cavity cancers include buccal mucosa, alveolus and gingival, hard palate and tongue and floor of the mouth cancers. Tumor Node Metastasis (TNM) classification is currently the most commonly used system for describing malignant tumors and their extent of spread (both regional and distant). This staging system is the guide for every radiologist for assessment of oral carcinomas as well as for reporting relevant studies.

MRI is a very useful tool for providing the details of structures within the oral cavity and also of the adjacent structures. Excellent soft-tissue discrimination of MRI readily reveals tumor invasion and spread to surrounding structures ([Figure 1](#f1-poljradiol-82-92){ref-type="fig"}). MRI is used to assess the extent of local and regional tumor spread, the depth of invasion, and the extent of lymphadenopathy ([Figure 2](#f2-poljradiol-82-92){ref-type="fig"}). The major advantage of MRI over computed tomography (CT) is that it provides excellent soft tissue details as compared to CT and does not expose the patients to any harmful radiations. MRI can detect marrow invasion by tumor earlier than CT. MRI provides information about the involvement of the base of the tongue, floor of the mouth, and is very useful to see the tumor extension into the oro-pharynx that is extremely difficult to be seen on CT ([Figure 3](#f3-poljradiol-82-92){ref-type="fig"}). The gadolinium chelates used as MRI contrast agents are associated with a much lower incidence of allergic/anaphylactic reactions and are less nephrotoxic in the doses used than the iodinated contrast agents used in CT \[[@b9-poljradiol-82-92]\].

Results of the study showed that the highest number of patients had tongue malignancy (about 82% of the patients). Early tumors of the tongue tend to be confined within the tongue ([Figure 1](#f1-poljradiol-82-92){ref-type="fig"}). The advanced tumors can invade the surrounding structures like the floor of the mouth, tongue base, mandible and the anterior tonsillar pillar ([Figure 4](#f4-poljradiol-82-92){ref-type="fig"}). Contrast-enhanced T1W images help assess marrow invasion, soft tissue extent, tumor thickness and best demonstrate necrosis in nodes ([Figure 3](#f3-poljradiol-82-92){ref-type="fig"}). MRI is also used to assess the extent of lymphadenopathy. It is used to assess the presence of occult metastatic lymph nodes. So the present study emphasized the importance of MR imaging as a valuable tool for carrying out the loco-regional staging of oral cavity cancers with an extreme degree of precision. The extent of primary tumor (T) and metastasis to regional lymph nodes (N) was initially evaluated by clinical examinations followed by MR imaging in this study. The final diagnosis was made by histopathological examination. Kappa Index was used for data analysis. Our study shows that there is moderate agreement (kappa value 0.537) between the clinical and MRI T staging. Clinical T staging changes in 32% of patients after performing MRI, which is finally proven by histopathological examination. This is consistent with the studies performed by Paiva RR et al. \[[@b10-poljradiol-82-92]\] and Paiboon JJ et al. \[[@b11-poljradiol-82-92]\] which also showed that mis-staging by clinical examination in the overall stage grouping was high.

Our study shows good/substantial agreement (kappa value 0.790) for the T staging (tumor depth and width) between MRI and pathological assessments. The final staging as assessed by MR imaging in our study remains the same in 19 out of 22 patients who underwent surgery and final staging by histopathological means. These results are consistent with the study conducted by Tetsumura A et al. \[[@b12-poljradiol-82-92]\] in which the tumor depth and width were measured on both MR images and histo-pathological sections and the authors observed a high correlation between the values measured by MRI and histopathology.

Zeng et al. \[[@b13-poljradiol-82-92]\] also conducted similar studies and founded that MRI showed good performance in displaying tumor invasion, invasion depth and extension. This is consistent with the present study which also shows good/substantial agreement (kappa value 0.790) for the T staging but shows only fair agreement (kappa value 0.458) for the N staging between MRI and pathological staging assessments.

Our study shows that MRI is an adequate technique for the assessment of oral cavity malignancies, in the evaluation of depth invasion, presence and extension of mandibular involvement (T stage), and shows excellent agreement with the final T staging by histopathology. This is consistent with the study conducted by Vidiri et al. \[[@b14-poljradiol-82-92]\] which also shows similar results.

Paul Lam et al. \[[@b15-poljradiol-82-92]\] also conducted a study in which the radiological tumor thickness on contrast-enhanced T1-weighted and T2-weighted images was compared with the histological tumor thickness. They concluded that MR images provide satisfactory accuracy for the measurement of tumor thickness and staging of oral tongue cancer. This is consistent with the results of our present study which also shows good/substantial agreement (kappa value 0.790) for the T staging between MRI and pathological staging assessments.

Conclusions
===========

A high correlation was found between the values measured by MRI and histopathology for thickness of the mucosal epithelium and both depth and width of tumors. MRI provides satisfactory accuracy for preoperative estimation of tumor thickness and paralingual distance, valuable for predicting occult cervical nodal metastasis. The mucosal epithelium, lamina propria and muscles of the tongue were clearly identifiable on MRI. MRI is the imaging modality of choice for staging of malignancy of the oral cavity and tongue using TNM classification which helps a clinician in planning treatment like glossectomy/marginal mandibulectomy or radiotherapy or both.
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![Shows a mass lesion with soft tissue signal intensity involving the right lateral border of the tongue, appearing isointense on T1W images (**A**), hyperintense on T2W (**B**), STIR sagittal (**C**), STIR coronal images (**D**), extending posteriorly to involve the posterior margin of the tongue, showing mild contrast enhancement on post-contrast T1W FS images (**E**) and restriction on diffusion weighted images (**F**).](poljradiol-82-92-g001){#f1-poljradiol-82-92}

![Shows a mass lesion with ill-defined soft tissue signal intensity, involving the buccal mucosa on the left side, opposite the second, third molars, appearing isointense on T1W (**A**), hyperintense on STIR coronal (**B**), T2W (C) images, extending to the left retromolar trigone with loss of fat planes with the buccinator muscle, showing minimal enhancement (**D**) and restriction on DWI (**E**). (**F**) shows enlarged lymph nodes at levels Ib, II on both sides.](poljradiol-82-92-g002){#f2-poljradiol-82-92}

![Shows a lesion with ill-defined soft tissue signal intensity, involving almost the whole tongue, appearing isointense on T1W (**A**), heterogeneously hyperintense on T2W images (**B**), showing moderate contrast enhancement (**C**). On DWI, it shows restriction (**D**). Posteriorly, it involves the base of the tongue and obliterates the oropharyngeal lumen. Multiple heterogeneously-enhancing lymph node masses seen along both jugular chains (**E, F**).](poljradiol-82-92-g003){#f3-poljradiol-82-92}

![Shows a mass lesion with ill-defined soft tissue signal intensity, involving the buccal space on the left side, appearing isointense on T1W (**A**), hyperintense on T2W (**B**) and STIR coronal images (**C**), showing mild enhancement (**D**). Restriction on DWI (**E**). Laterally, reaching up to subcutaneous tissues. Medially, indenting the left lateral margin of the tongue with well-defined fat planes in between. (**F**) shows enlarged lymph nodes at levels 1b, II, III on the left side.](poljradiol-82-92-g004){#f4-poljradiol-82-92}

###### 

AMerican Joint Committee on Cancer (AJCC) TNM staging.

  Stage   Description
  ------- ------------------------------------------------------------------------------------------------------------------------------------------------
  TX      Primary tumor cannot be assessed
  T0      No evidence of primary tumor
  Tis     Carcinoma *in situ*
  T1      Tumor ≤2 cm in greatest dimension
  T2      Tumor \>2 cm but ≤4 cm in greatest dimension
  T3      Tumor \>4 cm in greatest dimension
  T4a     Moderately advanced local disease, -- invades through cortical bone, into deep (extrinsic) muscles of tongue, maxillary sinus, or skin of face
  T4b     Very advanced local disease, -- invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery
  NX      Regional lymph nodes cannot be assessed
  N0      No regional lymph node metastasis
  N1      Metastasis in a single ipsilateral lymph node, ≤3 cm in greatest dimension
  N2a     Metastasis in single ipsilateral lymph node, \>3 cm but ≤6 cm in greatest dimension
  N2b     Metastases in multiple ipsilateral lymph nodes, none \>6 cm in greatest dimension
  N2c     Metastases in bilateral or contralateral lymph nodes, none \>6 cm in greatest dimension
  N3      Metastasis in a lymph node \>6 cm in greatest dimension
  M0      No distant metastasis
  M1      Distant metastasis

###### 

Pre- and postcontrast.

  SEQ                FOV   RFV   MATRIX    THK (MM)   GAP (MM)   NSA   TR     TE
  ------------------ ----- ----- --------- ---------- ---------- ----- ------ ----
  Pre contrast                                                                
   STIR (COR)        250   75    272/512   3.0        1.3        3     4340   14
   T1W COR           250   75    352/512   3.0        1.3        4     460    12
   T2W FS TRA        250   80    352/512   4.0        0.4        3     2548   80
   STIR SAG          250   75    272/512   3.0        1.3        3     4341   14
   T1W FS TRA        250   80    352/512   4.0        0.4        4     664    12
   T1 axial          250   80    352/512   4.0        0.4        4     460    12
   Diffusion axial   230   80    112/80    5.0        0.5        4     460    12
  Post contrast                                                               
   T1W FS            250   80    352/512   4.0        0.4        4     664    12
   T1W COR           250   80    352/512   3.0        1.3        3     460    12

###### 

Incidence of individual cancer.

  Site                         Number of patients   Percentage
  ---------------------------- -------------------- ------------
  Tongue                       41                   82%
  Buccal mucosa and alveolar   9                    18%
  Hard palate                  0                    0%
  Total                        50                   100%

Table 3 shows that maximum number of patients were of tongue malignancy followed by buccal mucosa and alveolar malignancy.

###### 

Age incidence.

  Age group in years   No. of patients   Percentage
  -------------------- ----------------- ------------
  ≤20                  0                 0%
  21--30               2                 4%
  31--40               11                22%
  41--50               13                26%
  51--60               16                32%
  \>60                 8                 16%
  Total                50                100%

Table 4 shows that maximum number of patients were in the age group of 51--60 followed by the age group of 41--50 years.

###### 

Sex incidence.

  Sex      Number of patients   Percentage
  -------- -------------------- ------------
  Male     48                   96%
  Female   2                    4%
  Total    50                   100%

Table 5 shows that incidence of the oral cancers is higher in males than females. Males were predominant in this study with 96% of the total patients were males and 4% were females. Male to female ratio is 24: 1.

###### 

Correlation between clinicaltumour (T) staging and MRI tumour (T) staging.

  Clinical 'T' staging   MRI 'T' staging   Total             
  ---------------------- ----------------- ------- ---- ---- ----
  T1                     2                 0       0    0    2
  T2                     0                 12      1    0    13
  T3                     0                 5       11   3    19
  T4                     0                 1       6    9    16
  Total                  2                 18      18   12   50

Table 6 correlates the MRI and clinical tumour (T) staging. By applying the chi square test and kappa statisitics, p value and k value comes out to be 0.01 and 0.537 respectively showing moderate agreement between the clinical and MRI staging assessments.

###### 

Correlation between clincal nodal (N) staging and MRI nodal (N) staging.

  Clinical 'N' staging   MRI 'N' staging   Total        
  ---------------------- ----------------- ------- ---- ----
  N0                     7                 4       8    19
  N1                     1                 9       11   21
  N2                     0                 0       10   10
  Total                  8                 13      29   50

Table 7 correlates the MRI and clinical nodal (N) staging. By applying the chi square test and kappa statisitics, p and k value comes out to be 0.02 and 0.328 respectively which shows fair agreement between the clinical and MRI staging assessments.

###### 

Correlation between MRI tumour (T) staging and histopathological tumour (T) staging.

  MRI 'T' staging   Histopathological 'T' staging   Total           
  ----------------- ------------------------------- ------- --- --- ----
  T1                1                               0       0   0   1
  T2                0                               9       0   0   9
  T3                0                               2       6   0   8
  T4                0                               1       0   3   4
  Total             1                               12      6   3   22

Table 8 correlates the MRI and histopathological tumour (T) staging. By applying the chi square test and kappa statisitics, p and k value comes out to be 0.01 and 0.790 respectively which shows good/substantial agreement between the clinical and MRI staging assessments.

###### 

Correlation between MRI nodal (N) staging and histopathological nodal (N) staging.

  MRI 'N' staging   Histopathological 'N' staging   Total       
  ----------------- ------------------------------- ------- --- ----
  N0                3                               0       0   3
  N1                3                               3       1   7
  N2                4                               0       8   12
  Total             10                              3       9   22

Table 9 correlates the MRI and histopathological (N) staging. By applying the chi square test and kappa statisitics, p and k value comes out to be 0.01 and 0.458 respectively which shows moderate agreement between the clinical and MRI staging assessments.

###### 

Clinical (T) staging *vs.* histopathological (T) staging.

  Clinical 'T' staging   Histopathological 'T' staging   Total           
  ---------------------- ------------------------------- ------- --- --- ----
  T1                     1                               0       0   0   1
  T2                     0                               6       1   0   7
  T3                     0                               3       3   1   7
  T4                     0                               3       2   2   7
  Total                  1                               12      6   3   22

Table 10 correlates the clinical and histopathological tumour (T) staging. By applying the chi square test and kappa statistics, p and k value comes out to be 0.01 and 0.085 respectively which shows poor agreement between the clinical and MRI staging assessments.

###### 

Clinical (N) staging *vs.* histopathological (N) staging.

  Clinical 'N' staging   Histopathological 'N' staging   Total       
  ---------------------- ------------------------------- ------- --- ----
  N0                     4                               0       3   7
  N1                     5                               3       4   12
  N2                     1                               0       2   3
  Total                  10                              3       9   22

Table 11 correlates the clinical and histopathological (N) staging. By applying the chi square test and kappa statistics, p and k value comes out to be 0.01 and 0.185 respectively which shows poor agreement between the clinical and MRI staging assessments.
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